AZBio News – June 2011

Biosphere 2 to Have a Permanent Home With the UA

New salmonella-based ‘clean vaccines’ aid the fight against infectious disease (ASUBiodesign)

BIO Unveils Strategic Initiative to Speed Scientific Breakthroughs, Develop Cures and Grow the Bio-Economy (BIO)

International Genomics Consortium contributes to The Cancer Genome Atlas’ detailed ovarian cancer analysis  Findings point to new means of assessing patient survival

Institute for Advanced Health Chooses Phoenix ~  Dr. Patrick Soon-Siong’s vision takes root in Phoenix.

The International Genomics Consortium has reached agreements with Scottsdale Healthcare and the University of Arizona Cancer Center to collect and store tumor samples for a nationwide research project that seeks to yield
genetic clues about the most common types of cancer.
(Arizona Republic)

LaBaer named Health Care Heroes finalist for discoveries in breast cancer detection and treatment.  (ASUBiodesign)

St. Joseph’s Hospital and Medical Center and Phoenix Children’s Hospital are
combining their pediatric neuroscience programs under the newly formed Barrow Neurological Institute at Phoenix Children’s Hospital.

CEO of AZBIO Member Firm Joins Select Group of Business Leaders as a Winner of Ernst & Young’s Entrepreneur Of The Year Award

Growing a better NIH: A radical way to fix the nation’s medical-research establishment – Michael M. Crow, President of Arizona State University (Boston Globe)

Improving Health Care with Better InformationTuscon Medical Center (TMC) leverages tech to improve patient care.

Arizona Board of Regents approves new Cancer Center in Downtown Phoenix

Looking Back and Looking Forward: A great video and a great legacy.  Thank you President Shelton for your commitment to leadership and to our AZBio community.

Tucson Medical Center, Independent Area Physicians Establish Region’s First Fully Operational Accountable Care Organization

Ventana’s Phil Miller recognized for improving the lives of millions of cancer
patients.

Regenesis Biomedical Announces $5.3 Million in Series C Funding

Phoenix Children’s Hospital debuts expanded campus (Business Journal)

BioVigilant Introduces Next-Generation Rapid Biologic Detection System to Safeguard Pharmaceutical Manufacturing Areas

First Things First

In an industry like ours, doing things in the right order matters.  It does not matter of you are working in the lab, biz dev or the front office.  When you forget to put first things first you might not get the outcome you expect…or need.

At AZBio we have been investing our time in research.  For us that means getting out of the office and into the  community to talk to Members, create opportunities to connect and to listen to what they have to say.  Whether we are are in one-on-one visits to Members and their companies, meetings at the GPEC, The Desert Angels or BCLSA or hanging out with the AZBio Gang at Beer and Bio, we’ve been asking questions and gathering data on what you, our members want and need.   So far this research has led to some new developments and there are a lot more coming,  Here are FIVE important things you said…Continue reading

AZBio News – April and May 2011

Green and lean: Secreting bacteria eliminate cost  barriers for renewable biofuel production

Kinetic Muscles, Inc. Celebrates 10 year anniversary

Yulex names Jim Mitchell COO by Angela Gonzales, Phoenix Business Journal

Laura Gonzalez selected for Phoenix Business Journal’s ‘Forty Under 40’ honors

ISO 13485 Certification Achieved by Regenesis Biomedical

Dr. David Eberhard joins Flagship as Chief Medical Pathologist

University of Minnesota licenses multiplexing software to Flagship Biosciences

AZBio News for March 2011

Apthera and RXi Pharmaceuticals Announce Definitive Merger Agreement

Ventana Medical Launches Virtuoso Software for Digital Pathology

Catalyst for Growth – AZ Bio moves forward with new CEO and an aggressive agenda

Gore Reports First Patient Treated in the U.S. using GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface on a Lower Profile Delivery System

MSDx Awarded $226,000 Arizona Commerce Authority Grant

AdvaMed Appoints Regenesis Biomedical Chief Executive to Board of Directors